Animal studies investigating the efficacy of neurotrophic factors as treatments for Parkinson's disease (PD) ideally require partial dopamine (DA) lesion models. The intra-striatal 6-hydroxydopamine (6-OHDA) lesion model may be suitable for this purpose. Although this model has been well characterized in rodents, it has not previously been used in monkeys. The goal of the present study was to characterize the behavioural effects of unilateral injections of 6-OHDA in the basal ganglia of common marmoset monkeys (Callithrix jacchus). Cell counts from tyrosine hydroxylase immunochemistry five months postlesion revealed DA cell loss in the substantia nigra on the lesioned side of~46% relative to the unlesioned side. 6-OHDA lesioned monkeys showed a variety of behavioural deficits. Apomorphine induced rotation and simple sensorimotor measures (head position bias and PD disability rating score) were most affected by the lesion. The largest deficits were seen at one or two weeks postsurgery but had recovered by week ten. 6-OHDA lesioned monkeys took longer to complete a more complex sensorimotor staircase task. At 3.5 months postlesion, 6-OHDA monkeys also showed deficits on an object retrieval task designed to measure sensorimotor planning and skilled hand use. aMethyl-p-tyrosine, a tyrosine hydroxylase inhibitor, reinstated those deficits which had undergone recovery in the lesioned animals and also exacerbated the deficits on the staircase task. This model has potential in assessing treatments for PD aimed at curtailing disease progression such as continuous delivery of neurotrophic factors.
Introduction
Studies investigating neurotrophic factors such as GDNF pose a particular challenge regarding the appropriate model needed to test its efficacy. In rodents, the in vivo model most commonly used in PD research involves the unilateral injection of 6-hydroxydopamine (6-OHDA) directly into the substantia nigra or the medial forebrain bundle (52) . These procedures produce DA depletions in the terminal striatal areas which are almost complete (37, 41) . In order to assess the neuroprotective efficacy of neurotrophic factors, however, a partial lesion animal model is required (5) . Ideally, such a model should parallel the gradual degeneration of DA neurones characteristic of PD where a small number of DA neurones remain at the end-stage of the disease (12, 25) . These remaining groups of neurones are the targets for neuroprotective strategies (33). Unfortunately, it is difficult to produce standardized partial lesions by making sub-total lesions within the substantia nigra or medial forbrain bundle (5) . An alternative approach has been developed in rats in which 6-OHDA is injected directly into the terminal areas in the striatum. In the past few years, this intrastriatal 6-OHDA model in rats has been well characterized and been shown to produce suitable partial DA lesions (2, 29, 34, 43) . In this model there is a gradual degeneration, in which the first stage of rapid cell loss (one to four weeks post-injection) is followed by protracted cell loss continuing for at least four months (51) . The majority of rat studies showing the neuroprotective and neuroregenerative capacity of GDNF have used this particular partial lesion model (10, 28, 30, 31, 36, (48) (49) (50) 59 ). For example, Kirik and colleagues (31) have shown that administration of a modified adeno-associated viral vector (AAV) expressing GDNF to rats prior to intrastriatal injection of 6-OHDA was able to protect dopamine cells against the toxic insult and also to result in preservation of function.
Before treatments using viral vectors expressing GDNF progress to clinical use their safety and efficacy in monkeys should be assessed as an intermediate step between rodent studies and patient trials for a number of reasons. For example, the putamen and caudate nucleus form a continuous structure in rodents whereas they are discrete structures in humans and monkeys.
Also, there are immunological and pharmacokinetic differences between primates and rodents.
Although there have been monkey studies in which GDNF has been evaluated, they have made use of the MPTP model of PD (11, 19, 21, 32, 60) . Since the majority of rodent studies rely on the intrastriatal 6-OHDA model, we thought it was important to investigate the efficacy of GDNF in monkeys based on the same model. This would allow for direct comparison with the majority of rodent studies testing GDNF. However, the 6-OHDA partial model has not yet been characterised in monkeys. The goal of the present study was to characterize the behavioural effects of 6-OHDA lesions within the dopaminergic terminal striatal area in the common marmoset monkey.
Methods

Animals and Surgery
All procedures were carried out under a Project Licence in accordance with the U.K. Animals (Scientific Procedures) Act 1986. Twelve adult common marmosets (Callithrix jacchus), 7 males and 5 females, were used. All were laboratory-bred, weighed 320-470g, and were aged 22-35 months at the start of the experiment. All the monkeys were housed with a cage-mate of similar age. Six monkeys (4 males, 2 females) were given 6-OHDA injections unilaterally, with 9 injections into the striatum (caudate, accumbens, putamen). Six monkeys (3 males, 3 females) were given saline control injections at the same sites. Attempts were made to ensure that each pair of cage-mates were given unilateral injections in opposite hemispheres. Thus 3 animals in each group had injections in the left hemisphere and 3 had injections in the right 8 hemisphere. The coordinates, derived from the stereotaxic atlas of Stephan et al (53) , are shown in Table 1. For surgery, monkeys were anaesthetized with alphaxalone-alphadolone (Saffan; ScheringPlough Ltd, Welwyn Garden City, UK; 1.5ml/kg given intramuscularly). Fifteen minutes later the monkeys were injected with pargyline (Sigma, St Louis, MO, USA; 50mg/kg, intraperitoneally), a monoamine oxidase inhibitor which prevents the metabolism of 6-OHDA, thus prolonging its neurotoxic effects. A supplementary dose of 0.3ml Saffan was given during surgery if necessary. 6-OHDA Hbr (Sigma, St Louis, MO, USA; 4mg/ml free base weight dissolved in 0.01% ascorbate/saline) was freshly prepared and stored on ice just before use.
Each injection of 2µl 6-OHDA was made at a rate of 0.5µl/min using a 29g injection needle which was left in place for a further four minutes after each injection had been made. Control monkeys underwent the same procedures with saline injections. Following surgery the monkeys were given an analgesic (Finadyne; Schering-Plough Animal Health, Mildenhall, UK; 0.1mg/kg, subcutaneously) and kept in a warm incubator until well enough to be returned to their home cage, usually the day following surgery. removed and placed in 4% paraformaldehyde solution for 24 hours, after which they were transferred to 30% sucrose solution in PBS for 4 days at 4 o C.
Sections were cut at 60µm thickness and 1 in 6 sections was stained with cresyl violet. One in 6 sections was stained for tyrosine hydroxylase (TH). The staining for TH was carried out on free-floating sections and was done separately for the cell bodies in the SN and the terminals in the striatum. For the cell bodies, sections were treated for 5 min with 10% methanol/10% hydrogen peroxide in distilled water, to remove endogenous peroxidase. Sections were then washed in Tris-buffered saline, pH7.4 (TBS) and then pre-incubated in 3% normal goat serum (NGS; Dako, UK) for one hour in TBS containing 0.2% Triton-X100 (TXTBS), to reduce non-specific staining. The sections were then incubated for 3 days at 4 o C in polyclonal tyrosine hydroxylase antibody (1:3000, Institute Jacques Boy, Rheims, France) in 1% NGS in TXTBS.
Sections were then washed in TBS and incubated in biotinylated anti-rabbit immunoglobulin (Dako, UK; 1:200 in 1% normal goat serum in TBS). Sections were then washed in TBS and incubated for 2 hours in a streptavidin-biotin-peroxidase kit (Dako, UK; in 1% NGS in TBS).
After washes in TBS and Tris buffer (0.05M Tris/HCL, pH 7.4), the sections were treated with 3,3'-diamino benzidine (1% in Tris buffer). The sections were washed in Tris buffer, mounted on 1% gelatin-coated microscope slides and left to dry over night. After rehydration and dehydration through graded alcohols, the slides were cleared in xylene and coverslipped using DPX mountant.
TH staining of the striatal terminals was carried out as above with a few modifications. To remove endogenous peroxidases, the sections were incubated for 10 minutes in 10% methanol/3% hydrogen peroxide. Potassium phosphate buffered saline (KPBS) was used instead of TBS for all rinses and solutions. The sections were not preincubated in NGS, but for all other steps NGS was used at 2% rather than 1%. The sections were incubated overnight at room temperature in a different polyclonal tyrosine hydroxylase antibody (1:2000, Pel-Freeze, Rogers, AR, USA; in 2% NGS in 0.25% triton in KPBS). The sections were incubated in the streptavidin-biotin-peroxidase kit for one hour rather than two.
Quantification of TH-immunoreactive cells (TH-IR) in the SNpc
Prior to analysis, the borders of the SNpc were defined. In the anterior sections, the pars compacta cells were the only TH cells visible. In the central and caudal sections the border between the ventral tegmental cell group and the pars compacta region was just lateral to the roots of the third nerve. At the most caudal level, the pars compacta was defined as the dense TH cell group ventral to the medial lemniscus and the retrorubral area. The TH positive cells in the pars retriculata (and therefore dorsal to the cerebral peduncle) were included in the cell counts. This definition led typically to 7-8 sections per monkey being measured.
The number of TH-IR cells was quantified using the unbiased stereological method of the optical fractionator (58) , as outlined in Kirik et al (29) . Sampling was done using an Olympus CAST-Grid system (Olympus Danmark A/S, Denmark). After the region of interest was delineated for each slide, the first sampling counting frame was randomly placed over the region of interest. The counting frame was then systematically moved through the counting area until the whole area was sampled. The size of the counting frame was predetermined and a frequency was chosen so that between 100 and 200 cells would be counted per SNpc. The total number of cells was estimated based on the optical fractionator formula (58) .
Quantification of striatal TH-IR fibre density
Optical densitometry readings were made of the TH-IR fibres in the striatum using a NIH 1.60
Image program on a Macintosh 7100/66 computer. The computer was connected to an MT1-72 CCD video camera and a constant illumination table. Readings were made from nine rostro-caudal levels of the striatum one millimetre apart starting from AP13.5 and moving caudally, according to the atlas of Stephan et al (53) . Readings from the corpus callosum were used to correct for non-specific background density levels.
Behavioural Tests
The person undertaking all the behavioural assessment (AE) was unaware of whether the monkeys had had 6-OHDA or saline injections.
Disability rating scale:
This rating scale was used to quantify a variety of behavioural signs which could be regarded as 'parkinsonian'. Although the current experiment involved monkeys with unilateral lesions, we have previously found that non-lateralised measures can be sensitive to unilateral lesions (LEA, personal observations). The degree to which monkeys presented parkinsonian features in both spontaneous and induced behaviour was recorded. The readings were made in the home room when other non-experimental monkeys in the room were active (e.g. mid-morning or mid-afternoon, but not immediately after feeding). For spontaneous behaviours, the observer stood approximately 2m in front of the cage, and scored the behaviour in 3 separate one minute intervals. The following were assessed: 1) akinesia, 2) climbing, 3) abnormal posture and 4) tremor. The monkeys were given a score from 0 to 3 for each of these behaviours for each minute, with 3 representing the most impairment and 0 being normal behaviour. For induced behaviour, the observer tempted each monkey 3 times with a small piece of marshmallow (~3mm 3 ) and on each occasion the monkey was given a score of 0 to 3 on: 1) clumsiness, 2) bradykinesia, and 3) poor balance. For each monkey the overall score consisted of the total scores for spontaneous and induced behaviours to give a score of 63 for maximum impairment. Monkeys were assessed before lesion and at one, 2, 6, and 10 weeks after the lesion. ascorbate in saline) immediately before being videotaped for 60min. Monkeys were assessed before lesion, at one week after the lesion for spontaneous rotation, and at 2, 6, and 10 weeks after the lesion for spontaneous and drug-induced rotation.
Head position bias:
Staircase task: The staircase task is analogous to the 'staircase test' used for rats (38, 39) to assess skilled forelimb reaching. For this task, monkeys were tested individually in their home cages after their cage mate had been removed for the duration of the test session. The test apparatus was fixed to the front of the cage and the monkey was required to reach through a vertical slot on the left or right side of a Plexiglass apparatus in order to retrieve syrup-soaked bread pieces (~5mm 3 ) arranged on a series of five steps ascending towards the midline. An angled inner wall ensured that the monkey had to use its left hand to retrieve bread from the left side and the right hand to retrieve bread from the right side. Each monkey was presented with 18 trials over 2-3 days. There were 6 trials in which both sets of steps were baited, 6
trials in which only the steps on the left were baited, and 6 trials in which only the steps on the right were baited. The trials were presented in a fixed balanced order and the monkey was allowed 5 min to complete each trial. The total number of pieces removed and the time taken to remove all bread pieces ('time-to-clear') were recorded. Monkeys were trained prelesion until they were familiar with the apparatus and could readily retrieve the bread pieces from all the steps. Monkeys were assessed before lesion and at 2, 6, and 10 weeks after the lesion.
Object retrieval task (ORT):
This was an adaptation of the ORT first used by Diamond and colleagues (13, 14) to measure the motor planning involved in making detour reaches around a transparent barrier to obtain a reward. A correct response required the monkey to be able to control its arm movements, to choose which arm to use on different trials, and to reach around rather than towards a transparent barrier. The latter requires the inhibition of a direct reach towards a visible reward. Training and testing was started approximately 3.5 months postlesion. The monkey was placed in a holding chamber which was opaque except for the transparent front face which had a horizontal slot through which the monkey could reach. This face could be covered by an opaque screen between trials. On each trial the monkey was required to reach through the slot to retrieve a piece of marshmallow from a transparent test box (5cm x 5cm x 5cm). The test box had only one open side which faced towards the monkey's left or right side, in a pseudorandom order across trials. Each monkey was given 22 trials each day and was allowed up to two minutes to retrieve the marshmallow on each trial.
Testing continued until the monkey had retrieved at least 20 marshmallow pieces in the 22 trials on each of three consecutive days or for 14 days. Data were analysed for the last three days of testing, i.e. 66 trials. Trials were scored 'perfect' if the reward was taken in one smooth movement using the appropriate arm (left on the left side, right on the right side). All other trials were scored 'imperfect'. For imperfect trials, the number of 'motor errors' and 'barrier reaches' were counted. A motor error occurred when the appropriate arm was directed towards the opening but the food piece was not retrieved because it was dropped or knocked aside. A barrier reach was a reach that encountered the front or the closed side of the box and was, therefore, unsuccessful in retrieving the reward. Repeated barrier reaches were frequently made within one trial and were scored as separate reaches. When the opening was facing the monkey's contralesional side, two types of barrier reach could be made: Type 1, when the appropriate contralesional hand encountered the closed front of the box and Type 2, when the inappropriate ipsilesional hand encountered the closed front or the closed ipsilesional side of the box. Similarly, when the opening was on the ipsilesional side two further types of barrier reach could be made: Type 3, when the inappropriate contralesional hand encountered the closed front or the closed contralesional side of the box and Type 4, when the appropriate ipsilesional hand encountered the closed front of the box (see Fig. 7 ).
Testing after a-methyl-p-tyrosine (AMPT) administration: At approximately 5 months postlesion, when all the previous behavioural testing had been completed, the monkeys were assessed after administration of AMPT, a tyrosine hydroxylase inhibitor which reduces dopamine levels. The monkeys were given doses of 0 (saline injection), 20, 80, 160, or 240mg/kg AMPT (Sigma, St Louis, MO, USA; dissolved in saline, intramuscularly), 3-4h before being tested on the disability rating scale, head position bias, and the staircase task.
AMPT injections were separated by at least 2 days.
Results
Statistical analysis: Postlesion data were analysed for within-and between-group effects using a repeated measures ANOVA. Where there were significant interactions, post hoc comparisons were made using Bonferroni t-tests. Prelesion comparisons between groups were made using t-tests.
Histology:
Nigral cell counts: 6-OHDA lesioned monkeys had a significant loss of TH-IR cells in the substantia nigra ipsilateral to the lesion, with an average cell count of only 46% of the cell count on the intact side (see Table 2 and Fig 1) . TH-density measures of the striatum: Injection of 6-OHDA resulted in a loss of TH-IR Fibres in the striatum (see Table 3 and Fig 2) . The density of TH staining in the injected hemisphere as a percentage of the density in the uninjected hemisphere was 66% for the caudate nucleus, access to the reward through the closed side of the box. In contrast, when the opening was on the ipsilesional side, the 6-OHDA lesioned monkeys did not make excess barrier reaches with either hand (see Fig 7) . There was no significant difference between the 6-OHDA lesioned monkeys and the sham lesioned monkeys in the number of motor errors made with either arm.
Discussion
The purpose of this study was to characterize the behavioural deficits occurring after unilateral injections of 6-OHDA into the caudate, accumbens and putamen in marmoset monkeys. Such injections produced a behavioural syndrome that was of limited duration for some measures, but that was reinstated by the administration of AMPT. 6-OHDA injections reduced the number of TH-IR cells within the substantia nigra to~46% and the TH-IR density in the striatum to~68% compared to the non-injected side.
Intrastriatal injections of 6-OHDA resulted in a variety of behavioural impairments. The lesioned monkeys displayed parkinsonian signs after surgery as measured by the disability rating scale. By 10 weeks postlesion, the rating score for 6-OHDA lesioned monkeys had recovered to prelesion levels. Treatment with AMPT reinstated a dose dependent deficit on this measure suggesting that functional compensation involving dopamine systems, such as its synthesis or storage, were involved in the recovery seen postlesion.
6-OHDA lesioned monkeys spent substantially more time with their head oriented towards their ipsilesional side, with the highest level being seen at one week postlesion. This impairment returned to baseline levels by 6 weeks postlesion. Head position bias has been shown to be a reliable measure of sensorimotor deficits in DA depleted marmosets. Annett and colleagues (1) reported that the greatest levels of head bias were seen one week after 6-OHDA lesions of the substantia nigra after which there was a gradual decline in the levels of bias, although the head bias did not return to prelesion levels in the case of these near complete dopamine lesions. In the present study the administration of AMPT reinstated head bias to levels seen at one week postlesion. This indicates that along with the disability rating scale, head position bias is a useful measure of behavioural deficit but sensitive to recovery.
The quantification of rotational behaviour occurring after unilateral lesions of the DA system is a standard tool for assessing dopamine loss within the nigrostriatal system (52) . In the present study, 6-OHDA lesioned monkeys rotated contralesionally after apomorphine administration at 2 and 6 weeks postlesion but had returned to baseline levels by week 10 postlesion. They did not, however, rotate spontaneously or in response to amphetamine. This differs from the effects of 6-OHDA lesions of the substantia nigra, nigrostriatal bundle or basal ganglia in rats or the effects of nigrostriatal bundle lesions in marmosets, where both amphetamine and apomorphine induced rotations are seen. A possible source for this discrepancy may lie in the level of locomotor activity resulting from injections of these two drugs. Unlesioned marmosets show a marked increase in locomotion in response to injections of apomorphine but not in response to injections of amphetamine over a wide dose range (45) .
If the level of locomotor activity contributes to the rate of rotation, particularly at lower lesion sizes, this may produce differential results. A rotational response to amphetamine may only be seen in marmosets with the very large unilateral DA depletions achieved by bundle nigrostriatal lesions.
The staircase task has previously been used in marmoset monkeys to assess skilled sensorimotor ability (24, 27) . 6-OHDA lesioned monkeys in the present study were slower and somewhat less successful at retrieving rewards in this task especially under AMPT, although there was no significant effect of side and, therefore, of hand. Unilateral 6-OHDA partial lesion studies in rats have shown a variable contralesional paw deficit, perhaps dependent on lesion size (2, 34, 34, 47) . Recovery of paw deficits may also occur (46) . Ipsilesional hand deficits may occur in sensorimotor tasks, particularly with the complete unilateral lesion model (e.g. (37, 38, 41) . Miklyaeva and colleagues (37) reported that ipsilesional deficits in a reaching task may occur as a consequence of postural abnormalities associated with unilateral nigrostriatal DA loss.
The object retrieval task was originally designed to measure deficits in human infants and rhesus monkeys (13) . The task assesses the degree to which monkeys are able to make detour reaches around a transparent barrier, an ability shown to be sensitive to DA loss (55) . In order to succeed monkeys need to refrain from making inappropriate arm movements that are directed at the barrier. Taylor and colleagues (55, 56) reaches towards the front barrier with that hand. However, they made even more barrier reaches in this position with their ipsilesional hand. This suggests that these monkeys were reluctant to use the appropriate contralesional hand, but were motivated enough to resort to using their inappropriate ipsilesional hand, thereby making a substantial number of barrier reaches with that hand. The increase in use of the ipsilesional hand is probably a natural consequence of this reluctance to use the contralesional hand rather than an effect of the lesion on the motor control of the ipsilesional arm. It is noteworthy that at three and a half months postlesion, at a time when behavioural recovery had taken place on other measures, the ORT was still able to detect sensorimotor behavioural deficits.
The tyrosine hydroxylase inhibitor AMPT reinstated or exacerbated deficits on the disability rating scale, head position bias and the staircase task. This suggests that compensatory mechanisms involving dopamine were involved in the recovery seen postlesion. Axonal sprouting of the remaining dopamine cells, an increase in TH activity and an increase in DA turnover have been observed to occur in rats after 6-OHDA lesions (18, 61) , and may be the basis of the recovery seen in the present study.
The present study has shown that intrastriatal 6-OHDA lesions of the DA system in marmoset monkeys result in a variety of behavioural deficits which parallel many of the deficits seen in rodent studies. A number of these deficits in marmosets are prone to recovery but are reinstated by the TH inhibitor AMPT. The development of a functionally more stable Table 2 for quantification of lesion. Bar = 1mm. Table 3 for quantification. Bar = 5mm. Filled columns: 6-OHDA injected group. *P<0.05, **P<0.01. The coefficient of errors for estimates of total cell counts were <0.1 for each group/side as calculated by the method of Gundersen and Jenson (22) . 
